1. Catalogs
  2. Sysmex Europe
  3. OSNA / RD-100i
video corpo

OSNA / RD-100i

OSNA / RD-100i

OSNA / RD-100i

Product catalog summary
Introduction
Sentinel node biopsy is the preferred surgical procedure for early-stage, clinically node-negative breast cancer patients. Traditional methods like frozen section or touch imprint with rapid H&E staining have low sensitivity due to limited tissue analysis, leading to potential false-negative results.
OSNA Technology
OSNA (One Step Nucleic Acid Amplification) is a novel diagnostic approach that allows for the analysis of the entire lymph node intra-operatively. It uses RT-LAMP technology to detect CK19 mRNA, an epithelial cell marker not normally present in lymph nodes. This method provides a comprehensive assessment of metastatic tumor burden, eliminating the need for a second surgery or confirmatory histopathological analysis.
Marker Selection
Sysmex selected CK19 mRNA as the optimal marker after evaluating 45 candidate mRNA markers. CK19 showed high expression in metastatic lymph nodes and low expression in non-metastatic nodes, ensuring high sensitivity and specificity.
RT-LAMP Technology
RT-LAMP is a rapid isothermal amplification procedure that completes in 16 minutes without RNA purification. It uses six primers to ensure high specificity and avoid false positives. The process is monitored in real-time, with results available in 30-45 minutes.
Clinical Validation
OSNA has been validated in multiple studies across different countries, showing high concordance with histopathological examination. It demonstrated a specificity of 100% in a Japanese study involving 144 lymph nodes from 60 pN0 patients.
Conclusion
OSNA is a reliable diagnostic tool for detecting lymph node metastases in breast cancer, fully compliant with IVD standards and approved for use in the EU.
See more

Catalog excerpts

OSNA / RD-100i-1

RD-100i OSNA – the new generation of sentinel lymph node analysis in breast cancer

 Open the catalog to page 1
OSNA / RD-100i-2

RD-100i OSNA – the new generation of sentinel lymph node analysis in breast cancer Sentinel node biopsy has rapidly emerged as the surgical procedure of choice for early stage, clinically node-negative breast cancer patients. Conventional intra-operative analysis of the sentinel lymph node (SLN) has, until now, been performed by frozen section or touch imprint with a rapid H & E (haematoxylin and eosin) staining. The sensitivity of these histopathological methods is low because only a small proportion of the lymph node tissue can be investigated in an intra-operative setting. As a result, there...

 Open the catalog to page 2
OSNA / RD-100i-3

Advanced technology OSNA is an automated molecular diagnostic assay using a rapid nucleic acid amplification technology (RT-LAMP*) for the detection of Cytokeratin 19 (CK19) mRNA expression. CK19 is an epithelial cell marker and normally not present in lymph node tissue. The amount of CK19 mRNA expression correlates with the size of metastatic foci: The system indicates the extent of the metas- tatic tumour burden. The basis for the evaluation of the patient result is by comparison to a standard curve with three different In a second step the seven most promising candidate markers with high mRNA...

 Open the catalog to page 3
OSNA / RD-100i-4

RT-LAMP technology The innovative amplification technology RT-LAMP is a rapid isothermal procedure offering several advantages in comparison to conventional PCR methods. The amplification reaction takes place within i6 min and no prior RNA purification is necessary. Conditions for sample preparation and the special primer design are tailored to ensure high specificity and to avoid false positive Six different primers are used in RT-LAMP specifically designed to avoid the amplification of CK19 pseudogenes or their transcripts, and furthermore to speed up the reaction of the assay. LAMP Primer...

 Open the catalog to page 4
OSNA / RD-100i-5

Clinical validation studies and results The OSNA method has been evaluated in multiple multicentric studies in different countries [1–5]. In all these studies OSNA was compared to an extensive histopathological examination. The lymph nodes were cut with a special cutter device into 4 slices of 1 or 2 mm width. Alternate slices were applied either to the OSNA assay or used for multilevel histology on permanent sections. Sections were taken from 5 levels with skip ribbons of 100, 200 or 250 µm. In summary, 2313 lymph nodes have been analysed and generated the following performance data: Concordance...

 Open the catalog to page 5
OSNA / RD-100i-6

Displayed parameters Tissue range per sample Sample volume Data storage Quality control Gene Amplification Detector System RD-100/ OSNA (One Step Nucleic Acid Amplification) RT-LAMP (Reverse transcriptase loop-mediated isothermal amplification) change of transmitted light caused by the precipitation of magnesium pyrophosphate depending on the grade of the reaction homogenising reagent LYNORHAG amplification reagent LYNOAMP BC positive and negative control 180 data points per file host computer connection (RS232, LAN) wxhxd [mm]/[kg] SNCS optional with Sysmex Service Agent and remote access Design...

 Open the catalog to page 6

All Sysmex Europe catalogs and technical brochures

  1. CA-620

    3  Pages

  2. UC-3500

    2  Pages

  3. XN-CBC

    7  Pages

Archived catalogs

  1. XN-550

    2  Pages

  2. XN-1000

    2  Pages

  3. XN-9000

    1  Page

  4. DI-60

    2  Pages

  5. pocH-100i

    3  Pages

  6. DigniLife

    2  Pages

  7. XN-2000

    2  Pages

  8. XT_4000i

    6  Pages

  9. XN-3000

    2  Pages

  10. XN-1000 Pure

    2  Pages

  11. XT-4000i

    3  Pages

  12. UD-10

    3  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.